Nippon Venture Capital Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 2
- Investments
- 82
- Portfolio
- 40
- Exits
- 25
Nippon Venture Capital General Information
Description
Nippon Venture Capital is the corporate venture arm of Nippon Telegraph and Telephone Corporation. The firm is focused on investing in seed, start-up and early stage companies operating in the communications, software, systems and devices, life sciences and environmental technologies sectors.
Contact Information
Website
Year Founded
1966
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
- 2-4-1 Marunouchi
- Chiyoda-ku
- Tokyo, 100-6334
- Japan
+81 00-0000-0000
Nippon Venture Capital Investments (82)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| J Pharma | 06-Jan-2021 | Later Stage VC | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | |
| 0000 & 0000000 | 16-Sep-2020 | 00000 00000 | 0000 | Consumer Finance | Generating Revenue | |
| 0000 0000000 | 01-Sep-2020 | 00000 00000 | 00.00 | Drug Discovery | Generating Revenue | 000000 000000 |
| 000000 | 20-Jul-2020 | 00000 00000 | 00.000 | Entertainment Software | Generating Revenue | |
| 000000 | 13-Mar-2020 | 00000 00000 | 00.000 | Business/Productivity Software | Generating Revenue | 000000 000000 |
| 00000 000000 | 26-Dec-2019 | 0000 00000 | 00.000 | Business/Productivity Software | Generating Revenue | 000000 000000 |
| 000000000 (0000000 | 22-Nov-2019 | 00000 00000 | 000.00 | Decision/Risk Analysis | Generating Revenue | |
| 000000 0000 | 21-Nov-2019 | 00000 00000 | 00.00 | Network Management Software | Generating Revenue | |
| Next Innovation | 01-Aug-2019 | Early Stage VC | Practice Management (Healthcare) | Generating Revenue | ||
| Chordia Therapeutics | 29-Mar-2019 | Early Stage VC | 0000 | Drug Discovery | Clinical Trials - Phase 1 |
Nippon Venture Capital Exits (25)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Kringle Pharma | 28-Dec-2020 | IPO | 00.000 |
| 00000 | 17-Dec-2020 | 000 | 00.000 |
| 00000 | 24-Jun-2020 | 000 | |
| 0000000 000000 | 01-Nov-2019 | 000 00 00000000 | |
| 00000 | 20-Aug-2019 | 000000000000000000 | |
| 00000000 0000 | 01-Feb-2019 | 000 00 00000000 | |
| 000000 000000000 | 15-Jan-2019 | 000000000000000000 | |
| 0000000000 | 22-Aug-2018 | 000 | 00.000 |
| Bplats | 04-Apr-2018 | IPO | 00.000 |
| Smart Insight | 16-Oct-2017 | Out of Business |
Nippon Venture Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialNippon Venture Capital Team (12)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Minoru Tagaya | President & Board Member | 0 | 0 | 0 | Tokyo, Japan |
| Koichiro Kiyonaga | Director, Managing Executive Officer and Board Member | Tokyo, Japan | |||
| Reiko Mizushima | Director, Managing Executive Officer and Board Member | Tokyo, Japan | |||
| Hiroyuki Kuwazono | Director, Senior Managing Executive Officer and Board Member | 0 | Tokyo, Japan | ||
| Chikara Shimizu | Venture Capitalist | Tokyo, Japan |
Nippon Venture Capital Co-Investors (78)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Mitsubishi UFJ Capital | 5 | 0 |
|
|
|
| SMBC Venture Capital | 0 |
|
|
||
| DG Ventures (Japan) | 0 | 0 | 0 |
|
|
| Eight Roads | 0 | 0 | 0 |
|
|
| Jafco | 0 | 0 |
|
|